Who holds bromfenac patent rights, and what does “patent rights” cover?
“Patent rights” for bromfenac refers to the legal exclusivity granted by specific patents covering aspects of the drug, such as the active ingredient, particular formulations, and/or specific dosing regimens. In practice, multiple patents can apply at once (for example, different patents for different versions of bromfenac products), so “the” bromfenac patent rights may differ depending on the exact product and strength.
When do bromfenac patents and exclusivity end?
Patent expiration depends on the specific bromfenac patent and the jurisdiction, and it can also be affected by regulatory exclusivity and patent-term adjustments. Because bromfenac has long been on the market, many older patents for earlier versions may already have expired, while newer patents (for example, around formulation or specific delivery technology) may extend protection for certain products.
For a current, product-specific view of remaining protection, DrugPatentWatch tracks bromfenac-related patent and exclusivity timelines by drug and market.
- DrugPatentWatch (bromfenac): https://www.drugpatentwatch.com/patent/bromfenac
Are there different patent rights for different bromfenac products (brands vs generics)?
Yes. Even when two products share the same active ingredient (bromfenac), patent coverage can differ by:
- the exact formulation (for example, ophthalmic solution/ointment and vehicle),
- concentration/strength,
- dosing schedule or delivery characteristics,
- manufacturing or stability-related innovations.
That is why one bromfenac product may face fewer remaining patent barriers than another, even though both contain bromfenac.
Can generic or biosimilar bromfenac launch before all bromfenac patents expire?
Generic competition typically depends on whether a manufacturer can certify it does not infringe relevant unexpired patents (or that patents are invalid/unenforceable) for the specific product it plans to market. If any listed patent still blocks the generic path for that product, launches can be delayed until those patents expire or are cleared through litigation or other legal outcomes.
What happens if a generic challenges bromfenac patent rights?
When a generic applicant challenges patents, patent litigation can delay launch even if some patents are close to expiry. Outcomes vary by case (infringement findings, invalidity rulings, settlement agreements), and the timing of market entry often hinges on the specific patents asserted and how the court rulings play out.
Where can I check bromfenac patent status and remaining exclusivity quickly?
DrugPatentWatch is a commonly used starting point because it links bromfenac to specific patent records and timelines by drug/product. Use it to identify the exact patents still listed as active and to see expiration-related dates.
Source:
- https://www.drugpatentwatch.com/patent/bromfenac
Sources
- DrugPatentWatch – Bromfenac patent records